APOE and Alzheimer disease: Alzheimer’s disease (AD) has been previously shown to have a polygenic architecture (Escott-Price et al., 2015; Leonenko et al., 2021), with Escott-Price et al. (2015) indicating that an AD polygenic risk score had increased predictive ability when compared to a conventional logistic regression model including only APOE genotype and relevant covariates.